Vertex Pharmaceuticals (VRTX) Return on Equity [ROE] (2010 - 2026)
Vertex Pharmaceuticals (VRTX) reported Return on Equity [ROE] of 19.32% for Q3 2026, down 1.99 percentage points from 21.31% a year earlier and down 2.92 percentage points from the prior quarter.
Vertex Pharmaceuticals (VRTX) Return on Equity [ROE] (2010 - 2026) Analysis & Trends
For FY2025, Vertex Pharmaceuticals posted Return on Equity [ROE] of 22.54%, up 25.69 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -14.17 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -3.15% in FY2024 (-26.14 pp), 22.99% in FY2023 (-4.68 pp), 27.67% in FY2022 (+2.74 pp) and 24.93% in FY2021 (-11.78 pp).
- The Q3 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q1 2025.
- Year over year, Return on Equity [ROE] gained in five of the last eight quarters, with an average year-over-year change of +6.12 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2026 (a gain of 28.83 percentage points); the low point was Q1 2025 (a drop of 28.26 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 22.24% (Q2 2026), 22.82% (Q1 2026) and 21.97% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 4.66% |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 19.32% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 19.32% |
| Jun 30, 2026 | 22.24% |
| Mar 31, 2026 | 22.82% |
| Dec 31, 2025 | 21.97% |
| Sep 30, 2025 | 21.31% |
| Jun 30, 2025 | 21.61% |
| Mar 31, 2025 | -6.01% |
| Dec 31, 2024 | -3.34% |
| Sep 30, 2024 | -3.16% |
| Jun 30, 2024 | -2.94% |
| Mar 31, 2024 | 22.25% |
| Dec 31, 2023 | 21.23% |
| Sep 30, 2023 | 21.70% |
| Jun 30, 2023 | 22.51% |
| Mar 31, 2023 | 23.00% |
| Dec 31, 2022 | 24.66% |
| Sep 30, 2022 | 26.22% |
| Jun 30, 2022 | 27.97% |
| Mar 31, 2022 | 23.34% |
| Dec 31, 2021 | 23.86% |
Vertex Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();